Thursday, November 28th, 2024
Cryptnox Secures Two Pioneering Patents in Web3 Hardware Wallet Technology
Geneva, Switzerland, 27th November 2024, ZEX PR WIRE, Cryptnox, a leader in next-generation security solutions for digital assets, proudly announces the acquisition of two groundbreaking patents: Patent No. US 12,101,400 B2 and Patent No. US 12,132,824 B2. These patents solidify Cryptnox’s position at the forefront of the Web3 hardware wallet industry, underscoring the company’s commitment to innovation and enhanced security in the digital finance space. Revolutionizing Data Security with Patent No. US 12,101,400 B2 The first patent, US 12,101,400 B2, covers a state-of-the-art method for data security. This method involves splittingRead More
Belle Clinic has Emerged as a Popular Laser and Aesthetic Clinic in London for Its Professional Treatments
Belle Clinic offers result-driven treatments for skin, tattoo, body and face London, United Kingdom, 27th Nov 2024 – Belle Clinic, a nurse-led Laser & Aesthetic clinic in London, has made its name for its dedication to providing creative, cost-effective, and results-driven care, transforming how patients view body sculpting and attractiveness. Founded in 2012, the company offers a wide range of advanced slimming and beauty treatments, including Fat Freezing, Cryolipolysis, Coolsculpting, HIFU treatments, and double chin removal. These procedures guarantee safe and transformational effects and are perfect for tackling stubborn fatRead More
Royal Hound and FCI Collaborate on Advanced Canine Health Clinical Research, Gaining International Attention
UK-based pet pharmaceutical company Royal Hound, in collaboration with the Fédération Cynologique Internationale (FCI), is conducting an advanced clinical research project centered on canine health and well-being, garnering substantial international attention. This study aims to collect scientific data that can enhance overall canine health and facilitate disease prevention and management. Through its collaboration with FCI, Royal Hound is conducting high-quality research that meets global standards, aiming to provide differentiated and tailored health solutions suited to various ages and breeds. A representative from Royal Hound stated, “We are committed to ongoingRead More
Royal Hound Begins Additional Clinical Study on Canine Supplement Safety in Collaboration with the American Kennel Club (AKC)
British pet pharmaceutical company Royal Hound has initiated a large-scale clinical study in collaboration with the American Kennel Club (AKC) to assess the safety and long-term efficacy of its canine nutritional supplements. This study aims to rigorously evaluate the effectiveness and safety of essential supplement ingredients that contribute to canine nutritional balance and long-term health, with the goal of collecting data that adheres to international standards. Royal Hound has garnered widespread acclaim in global markets, including Europe, for its development of tailored solutions that align with dogs’ characteristics and lifeRead More